HOXC13 and cancer: Some studies have found that the expression of HOXC13-AS is dysregulated in various types of malignant tumors, and upregulated HOXC13-AS expression is associated with clinical pathological features such as tumor node metastasis (TNM) staging, metastasis, clinical staging, and prognosis (Gao et al., 2019; Zhou J. F. et al., 2019).